Atlas Trials

Retrospective Survey of Re-treatment With Bortezomib

Clinical trial NCT01524445 · COMPLETED

Trial details

NCT number
NCT01524445
Sponsor
Janssen Pharmaceutica N.V., Belgium
Status
COMPLETED
Study type
OBSERVATIONAL
Hematological CancerMultiple Myeloma
Start date
2011-03-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.